The Children's Hospital of Philadelphia - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence

The Children's Hospital of Philadelphia - Pharmaceuticals & Healthcare - Deals and Alliances Profile

The Children's Hospital of Philadelphia - Pharmaceuticals & Healthcare - Deals and Alliances Profile - GlobalData Financial Mergers and Acquisitions Intelligence
The Children's Hospital of Philadelphia - Pharmaceuticals & Healthcare - Deals and Alliances Profile
Published Sep 23, 2016
32 pages — Published Sep 23, 2016
Price US$ 250.00  |  Buy this Report Now

About This Report

  
Abstract:

Summary

The Children's Hospital of Philadelphia (CHOP) is a childcare specialty hospital that provides pediatric healthcare solutions. The hospital concentrates on improving pediatric healthcare, and promotes childrens health through its medical discoveries. It carries out research in the areas of cardiac, genetics, cancer, orthopedics, fetal surgery, neonatology, gastroenterology and urology at its Children's Hospital of Philadelphia Research Institute. CHOP provides specialty programs for rare disorders such as thoracic insufficiency syndrome, hyperinsulinism, Cornelia de lange syndrome, eosinophilic esophagitis and biliary atresia.

The Children's Hospital of Philadelphia - Pharmaceuticals & Healthcare - Deals and Alliances Profile provides you comprehensive data and trend analysis of the company's Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharmaceuticals & Healthcare eTrack deals database, and primary and secondary research.


Scope

- Financial Deals - Analysis of the company's financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year - Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type - Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region - Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector - Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals - Information on the company's major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company's (major public companies) key financial metrics and ratios.
- Business Description - A brief description of the company's operations.
- Key Employees - A list of the key executives of the company.
- Important Locations and Subsidiaries - A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors - A list of the key competitors of the company.
- Key Recent Developments - A brief on recent news about the company.


Reasons to Buy

Get detailed information on the company's financial deals that enable you to understand the company's expansion/divestiture and fund requirements
- The profile enables you to analyze the company's financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company's business segments' expansion / divestiture strategy
- The profile presents deals from the company's core business segments' perspective to help you understand its corporate strategy.

Access elaborate information on the company's recent financial deals that enable you to understand the key deals which have shaped the company
-

  
Source:
Document ID
GDPH89641D
Country
Industry
Format:
PDF Adobe Acrobat
Buy Now

Sections

TitleStarting PageNumber of Pages
Table of Contents23
  List of Tables31
  List of Figures41
The Children's Hospital of Philadelphia, Pharmaceuticals &Healthcare, Deals By Year, 2010 to YTD 201642
The Children's Hospital of Philadelphia, Pharmaceuticals &Healthcare Deals By Type, 2010 to YTD 201661
The Children's Hospital of Philadelphia, Pharmaceuticals &Healthcare, Deals By Region, 2010 to YTD 201671
The Children's Hospital of Philadelphia, Pharmaceuticals &Healthcare, Deals By Therapy Area, 2010 to YTD 201681
The Children's Hospital of Philadelphia, Medical Devices Deals, 2010 to YTD 201691
The Children's Hospital of Philadelphia, Pharmaceuticals &Healthcare, Deals Summary, 2010 to YTD 2016102
The Children's Hospital of Philadelphia, Pharmaceuticals &Healthcare, Deal Details1216
  Venture Financing121
    Spark Therapeutics Raises USD73 Million in Series B Financing122
    Spark Therapeutics Raises US$50 Million In Venture Financing141
  Partnerships151
    Biobase Enters Into Licensing Agreement With University of Southern California And Children s Hospital of Philadelphia152
    Wave Life Sciences Enters into Research Agreement with Children s Hospital of Philadelphia172
    Emory University And Children's Hospital of Philadelphia Enter Into Co-Development Agreement With Harvard University191
    Children's Hospital of Philadelphia Partners BGI201
  Licensing Agreements211
    Medgenics Extends Agreement with Children's Hospital of Philadelphia211
    Omixon Enters into Licensing Agreement with Children's Hospital of Philadelphia221
    Spark Therapeutics Enters into Licensing Agreement with Children s Hospital of Philadelphia232
    Kolltan Pharma Enters Into Licensing And Research Agreement With Children's Hospital of Philadelphia For Pediatric Neuroblastoma Therapies251
    Eqalix Enters Into Licensing Agreement With Drexel University, University of Pennsylvania And Children's Hospital of Philadelphia261
  Debt Offering271
    Children s Hospital Of Philadelphia Completes Private Placement Of Fixed-Rate Bonds For US$270 Million271
The Children's Hospital of Philadelphia - Key Competitors281
Key Employees291
Locations And Subsidiaries302
  Head Office301
  Other Locations &Subsidiaries302
Appendix321
  Methodology321
  About GlobalData321
  Contact Us321
  Disclaimer321

Table Of Contents

About the Author


Cite this Report

  
MLA:
GlobalData Financial Mergers and Acquisitions Intelligence. "The Children's Hospital of Philadelphia - Pharmaceuticals & Healthcare - Deals and Alliances Profile" Sep 23, 2016. Alacra Store. Nov 16, 2026. <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Children-s-Hospital-of-Philadelphia-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7740>
  
APA:
GlobalData Financial Mergers and Acquisitions Intelligence. (2016). The Children's Hospital of Philadelphia - Pharmaceuticals & Healthcare - Deals and Alliances Profile Sep 23, 2016. New York, NY: Alacra Store. Retrieved Nov 16, 2026 from <http://www.alacrastore.com/storecontent/GlobalData-Financial-Mergers-and-Acquisitions-Intelligence/The-Children-s-Hospital-of-Philadelphia-Pharmaceuticals-Healthcare-Deals-and-Alliances-Profile-2148-7740>
  
US$ 250.00
$  £  €
Have a Question?

Any questions about the report you're considering? Our Customer Service Team can help! Or visit our FAQs.

More Research